3.57
Atai Life Sciences N V Borsa (ATAI) Ultime notizie
Atai Life Sciences (ATAI) Shares Drop 12% After Schizophrenia Drug Trial Setback - GuruFocus
Atai Life Sciences down 12% after hours on mid-stage failure of schizophrenia asset - Seeking Alpha
Clinical Trial Reveals Promising Signals for New Schizophrenia Cognitive Drug Despite Missed Endpoint - Stock Titan
Canaccord Increases Atai Life Sciences (ATAI) PT, Keeps Buy Rating - Insider Monkey
10 Best Performing Penny Stocks So Far in 2025 - Insider Monkey
What drives Atai Life Sciences N.V. stock priceHigh-velocity capital appreciation - PrintWeekIndia
Is Atai Life Sciences N.V. a good long term investmentBreakout profit opportunities - PrintWeekIndia
Canaccord Genuity Lifts Atai Life Sciences N.V. (ATAI)’s Price Target To $12, Maintains Buy Rating - MSN
What analysts say about Atai Life Sciences N.V. stockMassive wealth growth - Autocar Professional
5-HT2 Agonist Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, Mechanism of Action, Route of Administration, and Companies by DelveInsight - The Globe and Mail
atai Life Sciences (ATAI) Upgraded to Strong Buy: Here's Why - Yahoo Finance
atai Life Sciences Bets Big On Psychedelics For Mental Health - Finimize
ATAI Impresses, CDTX Navigates With Confidence, MTSR Builds Momentum, COGT Keeps Scaling The Summit… - RTTNews
Atai Life Sciences N.V. Stock Analysis and ForecastFastest return on investment - jammulinksnews.com
Don't Trip. These Psychedelic Stocks May Have Some Life in Them Yet - US News Money
Why Atai Life Sciences N.V. stock attracts strong analyst attentionBreakout Momentum Stocks - beatles.ru
why atai life sciences n.v. stock attracts strong analyst attentionDaily Breakout Picks - Newser
How Atai Life Sciences N.V. stock performs during market volatilityMomentum Swing Watchlist - Newser
Aegis Capital Reaffirms Buy on Atai Life Sciences N.V. (ATAI) with $8 Target - Insider Monkey
Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Atai Life Sciences, Beckley Psytech Announce Positive Topline Results for BPL-003 - Yahoo.co
13 Best German Stocks to Invest in Now - Insider Monkey
Retail investors are Atai Life Sciences N.V.'s (NASDAQ:ATAI) biggest owners and were rewarded after market cap rose by US$121m last week - Yahoo Finance
atai Life Sciences stock rating reiterated at Buy by Aegis Capital - Investing.com Australia
atai Life Sciences stock maintains Buy rating after positive Phase 2b results - Investing.com
atai Life Sciences stock price target raised to $12 by Canaccord on positive trial data - Investing.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):